Position in ABBV
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$507,809
+$73,699 QoQ
Shares Held
2,018
+1.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#3,138
of 4,153 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026REAP Financial Group, LLC holds $2,655,040 across 8 Drug Manufacturers - General names. ABBV ranks #3 (19.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
3,097 | $786,545 | |
| 2 | LLY |
ELI LILLY & Co
|
502 | $602,113 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
2,018 | $507,809 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,341 | $300,818 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,239 | $156,535 | |
| 6 | PFE |
Pfizer Inc
|
6,242 | $150,307 | |
| 7 | AMGN |
Amgen Inc
|
271 | $98,134 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
916 | $52,779 |
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $507,809 | 2,018 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $434,110 | 1,996 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $400,542 | 1,753 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $329,018 | 1,421 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $212,534 | 1,145 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $135,768 | 648 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $90,804 | 511 | Shares | Sole | 2025-02-27 | |
| 2024-09-30 | $80,571 | 408 | Shares | Sole | 2025-02-27 | |
| 2024-06-30 | $72,209 | 421 | Shares | Sole | 2025-02-27 | |
| 2024-03-31 | $74,114 | 407 | Shares | Sole | 2025-02-27 | |
| 2023-12-31 | $202,700 | 1,308 | Shares | Sole | 2025-02-27 | |
| No filing history on record for this holder in this stock. | ||||||